Aromasin is the brand name for the generic drug exemestane, which belongs to a class of medications known as aromatase inhibitors. Aromasin is primarily used in the treatment of breast cancer. Specifically, it is used in postmenopausal women who have hormone receptor-positive breast cancer.
Aromasin works by inhibiting the enzyme aromatase, which is responsible for converting androgens (male hormones) into estrogen (female hormones) in the body. Many breast cancers are hormone receptor-positive, which means they are stimulated to grow by estrogen. By blocking the production of estrogen, Aromasin can help slow down or inhibit the growth of hormone receptor-positive breast cancer cells.
Aromasin is typically prescribed as an adjuvant treatment in postmenopausal women who have undergone surgery or other primary treatments for breast cancer to reduce the risk of cancer recurrence. It may also be used in advanced or metastatic breast cancer cases when other treatments have proven ineffective.
It's important to note that Aromasin should only be used under the guidance and supervision of a qualified healthcare provider, as it can have side effects and should be carefully considered in the context of an individual's overall cancer treatment plan.
